Skip to main content
Log in

Predictors of thrombus formation after percutaneous left atrial appendage closure using the WATCHMAN device

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Percutaneous left atrial appendage (LAA) closure using the WATCHMAN device is a novel option for prevention of stroke associated with atrial fibrillation. However, device-related thrombus (DRT) formation is a concern after WATCHMAN implantation and the predictors of DRT still remain unclear. We aimed to clarify the predictors of DRT after WATCHMAN implantation by analyzing 78 patients (50 males, 72 ± 8 years, average CHA2DS2-VASc score of 4.3 + 1.8) who had undergone WATCHMAN implantation. WATCHMAN was successfully implanted in all patients and four (5%) developed DRT. Patients with DRT were more often female (75 vs. 34%, p = 0.094). CHA2DS2-VASc score was higher for patients with DRT (6.3 ± 2.5 vs. 4.2 ± 1.7, p = 0.022). Chronic kidney disease (100% vs. 43%, p = 0.024) and deep implantation of the device, which was defined as implant position below the LAA ostial plane (75 vs. 24%, p = 0.026), were more common in patients with DRT. HAS-BLED score (4.5 ± 1.0 vs. 3.5 ± 1.1, p = 0.074) was higher and oral anticoagulants (50 vs. 84%, p = 0.086) were less commonly prescribed for patients with DRT. Multivariable logistic regression analysis showed that higher CHA2DS2-VASc score (p = 0.022, OR 2.8) and deep implantation (p = 0.032, OR 24.7) were associated with DRT. These results suggest the possible role of CHA2S2-VASc scores and implantation depth in the development of DRT after percutaneous LAA closure using the WATCHMAN device.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Fountain RB, Holmes DR, Chandrasekaran K, Packer D, Asirvatham S, Van Tassel R, Turi Z (2006) The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial. Am Heart J 151:956–961

    Article  Google Scholar 

  2. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P (2009) Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. The Lancet 374:534–542

    Article  CAS  Google Scholar 

  3. Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, Halperin JL, Holmes D (2013) Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation 127:720–729

    Article  PubMed  Google Scholar 

  4. Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, Huber K, Whisenant B, Kar S, Swarup V, Gordon N, Holmes D (2014) Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA 312:1988–1998

    Article  Google Scholar 

  5. Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S (2011) Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 123:417–424

    Article  PubMed  Google Scholar 

  6. Main ML, Fan D, Reddy VY, Holmes DR, Gordon NT, Coggins TR, House JA, Liao L, Rabineau D, Latus GG, Huber KC, Sievert H, Wright RF, Doshi SK, Douglas PS (2016) Assessment of Device-Related Thrombus and Associated Clinical Outcomes With the WATCHMAN Left Atrial Appendage Closure Device for Embolic Protection in Patients With Atrial Fibrillation (from the PROTECT-AF Trial). Am J Cardiol 117:1127–1134

    Article  PubMed  Google Scholar 

  7. Hahn RT, Abraham T, Adams MS, Bruce CJ, Glas KE, Lang RM, Reeves ST, Shanewise JS, Siu SC, Stewart W, Picard MH (2013) Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr 26:921–964

    Article  Google Scholar 

  8. Kitkungvan D, Nabi F, Ghosn MG, Dave AS, Quinones M, Zoghbi WA, Valderrabano M, Shah DJ (2016) Detection of LA and LAA Thrombus by CMR in Patients Referred for Pulmonary Vein Isolation. JACC Cardiovasc Imaging 9:809–818

    Article  PubMed  Google Scholar 

  9. Seward JB, Khandheria BK, Oh JK, Freeman WK, Tajik AJ (1992) Critical appraisal of transesophageal echocardiography: limitations, pitfalls, and complications. J Am Soc Echocardiogr 5:288–305

    Article  CAS  PubMed  Google Scholar 

  10. Castello R, Pearson AC, Fagan L, Labovitz AJ (1990) Spontaneous echocardiographic contrast in the descending aorta. Am Heart J 120:915–919

    Article  CAS  Google Scholar 

  11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130:461–470

    Article  CAS  PubMed  Google Scholar 

  12. Kaneko H, Neuss M, Schau T, Weissenborn J, Butter C (2016) Impact of left ventricular systolic dysfunction on the outcomes of percutaneous edge-to-edge mitral valve repair using MitraClip. Heart Vessels 31:1988–1996

    Article  PubMed  Google Scholar 

  13. Miyamoto K, Aiba T, Arihiro S, Watanabe M, Kokubo Y, Ishibashi K, Hirose S, Wada M, Nakajima I, Okamura H, Noda T, Nagatsuka K, Noguchi T, Anzai T, Yasuda S, Ogawa H, Kamakura S, Shimizu W, Miyamoto Y, Toyoda K, Kusano K (2016) Impact of renal function deterioration on adverse events during anticoagulation therapy using non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Heart Vessels 31:1327–1336

    Article  PubMed  Google Scholar 

  14. Kondo T, Yamada T, Morita T, Furukawa Y, Tamaki S, Iwasaki Y, Kawasaki M, Kikuchi A, Kawai T, Takahashi S, Ishimi M, Hakui H, Ozaki T, Sato Y, Seo M, Sakata Y, Fukunami M (2016) The CHADS2 score predicts ischemic stroke in chronic heart failure patients without atrial fibrillation: comparison to other stroke risk scores. Heart Vessels. doi:10.1007/s00380-016-0861-7

    Google Scholar 

  15. Yamashita Y, Takagi D, Hamatani Y, Iguchi M, Masunaga N, Esato M, Chun YH, Itoh H, Nishimura M, Wada H, Hasegawa K, Ogawa H, Abe M, Akao M (2016) Clinical characteristics and outcomes of dialysis patients with atrial fibrillation: the Fushimi AF Registry. Heart Vessels 31:2025–2034

    Article  PubMed  Google Scholar 

  16. Kar S, Hou D, Jones R, Werner D, Swanson L, Tischler B, Stein K, Huibregtse B, Ladich E, Kutys R, Virmani R (2014) Impact of Watchman and Amplatzer devices on left atrial appendage adjacent structures and healing response in a canine model. JACC Cardiovasc Interv 7:801–809

    Article  Google Scholar 

  17. Gasparini M, Ceriotti C, Bragato R (2012) Huge left atrial thrombus after left atrial appendage occlusion with a Watchman device. Eur Heart J 33:1998

    Article  PubMed  Google Scholar 

  18. Ketterer U, D’Ancona G, Siegel I, Ortak J, Ince H, Kische S (2016) Percutaneous left atrial appendage occlusion: Device thrombosis in clopidogrel non-responders. Int J Cardiol 204:196–197

    Article  PubMed  Google Scholar 

  19. Boersma LV, Schmidt B, Betts TR, Sievert H, Tamburino C, Teiger E, Pokushalov E, Kische S, Schmitz T, Stein KM, Bergmann MW (2016) Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J 37:2465–2474

    Article  PubMed  PubMed Central  Google Scholar 

  20. Schneider B, Stollberger C, Sievers HH (2005) Surgical closure of the left atrial appendage—a beneficial procedure? Cardiology 104:127–132

    Article  PubMed  Google Scholar 

  21. Rosenzweig BP, Katz E, Kort S, Schloss M, Kronzon I (2001) Thromboembolus from a ligated left atrial appendage. J Am Soc Echocardiogr 14:396–398

    Article  CAS  PubMed  Google Scholar 

  22. Lam SC, Bertog S, Sievert H (2015) Incomplete left atrial appendage occlusion and thrombus formation after Watchman implantation treated with anticoagulation followed by further transcatheter closure with a second-generation Amplatzer Cardiac Plug (Amulet device). Catheter Cardiovasc Interv 85:321–327

    Article  PubMed  Google Scholar 

  23. Reddy VY, Mobius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, Sick P, Sievert H (2013) Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol 61:2551–2556

    Article  PubMed  Google Scholar 

  24. Beppu S, Nimura Y, Sakakibara H, Nagata S, Park YD, Izumi S (1985) Smoke-like echo in the left atrial cavity in mitral valve disease: its features and significance. J Am Coll Cardiol 6:744–749

    Article  CAS  Google Scholar 

  25. Tsai LM, Chen JH, Fang CJ, Lin LJ, Kwan CM (1992) Clinical implications of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation. Am J Cardiol 70:327–331

    Article  CAS  PubMed  Google Scholar 

  26. Chimowitz MI, DeGeorgia MA, Poole RM, Hepner A, Armstrong WM (1993) Left atrial spontaneous echo contrast is highly associated with previous stroke in patients with atrial fibrillation or mitral stenosis. Stroke 24:1015–1019

    Article  CAS  Google Scholar 

  27. Leung DY, Black IW, Cranney GB, Hopkins AP, Walsh WF (1994) Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. J Am Coll Cardiol 24:755–762

    Article  CAS  Google Scholar 

  28. Fatkin D, Kelly R, Feneley MP (1994) Left atrial appendage blood velocity and thromboembolic risk in patients with atrial fibrillation. J Am Coll Cardiol 24:1429–1430

    Article  CAS  PubMed  Google Scholar 

  29. Fatkin D, Kelly RP, Feneley MP (1994) Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 23:961–969

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all staff of the intervention laboratory in our institute.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christian Butter.

Ethics declarations

Conflict of interest

The authors report no relationships that could be construed as a conflict of interest regarding this study.

Funding

This work was supported by the Japan Society for the Promotion of Science (Hidehiro Kaneko).

Additional information

Hidehiro Kaneko and Michael Neuss contributed equally to this publication (share first authorship).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaneko, H., Neuss, M., Weissenborn, J. et al. Predictors of thrombus formation after percutaneous left atrial appendage closure using the WATCHMAN device. Heart Vessels 32, 1137–1143 (2017). https://doi.org/10.1007/s00380-017-0971-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-017-0971-x

Keywords

Navigation